PMC-Pharmerica Stock Research, Ratings, and Analysis

Pharmerica (pmc) Stock Research

Last Updated by Anonymous | Update This Page Now

►Summary | Profile | News | Chart | SWOT | Cash Flow | Comps | Buffett | WACC

Long Term Rating Stock Ratings Help

HOLD

SWOT Statistics pmc SWOT Analysis

Strengths + Opportunities = 0

Threats + Weaknesses = 1

Add your knowledge to the Pharmerica SWOT analysis.

Generic Strategy pmc Generic Strategy

Narrow Scope

Broad Scope

None

Uniqueness

Low Cost

Generic strategies categorize companies by the scope and the strength of their business. Pharmerica does not have a definable strategy, therefore, it risks losing out to firms that concentrate on one particular competitive advantage. (read more).

Company Description: PharMerica Corporation offers pharmacy services to healthcare facilities and hospitals in the US. The company purchases, packages, and dispenses requested pharmaceuticals and delivers them healthcare facilities, nursing and assisted living facilities, and other long-term alternative care settings. It also provides nursing homes and hospitals with federal compliance consultation, infusion therapy products and services, pharmacy operations, financial management services, and clinical pharmacy programs. Update

Market Research Update

Discretionary Industry Analysis: The consumer discretionary industry includes companies whose sales come from consumer discretionary income purchases. Discretionary income = gross income less taxes and necessities such as rent, mortgage and food. Discretionary Trading Strategy: The consumer discretionary industry tends to be very sensitive to economic cycles. Look for undervalued discretionary investments during economic recessions when stock prices are low and sell discretionary investments during the late stages of a bull markets when stock prices are high. The global economy is currently in a recession, therefore, it is the perfect time to purchase consumer discretionary investments. Upward sloping stock charts and financial news may indicate a selling opportunity while the opposite means that stocks are becoming undervalued.

Industry Sub Sector: . Pharmerica is a dominant industry leader due to its personnel, experience and financial strengths. Industry leaders are difficult to compete against, which decreases business and investor risks.

Market Challenges: Opportunities: Solutions:

Strategy Analysis Update

Strategy: Competitive Advantages:

Financial Analysis Update

Current Revenue Sources: Future Revenue Sources: